Concomitant expressions of
glycan-
binding proteins and their bound
glycans regulate many pathophysiologic processes, but this issue has not been addressed in
liver fibrosis. Activation of hepatic stellate cells (HSCs) is a rate-limiting step in
liver fibrosis and is an important target for
liver fibrosis therapy. We previously reported that
galectin (Gal)-1, a β-galactoside-
binding protein, regulates myofibroblast homeostasis in oral
carcinoma and wound healing, but the role of
Gal-1 in HSC migration and activation is unclear. Herein, we report that
Gal-1 and its bound
glycans were highly expressed in fibrotic livers and activated HSCs. The cell-surface glycome of activated HSCs facilitated
Gal-1 binding, which upon recognition of the N-
glycans on
neuropilin (NRP)-1, activated
platelet-derived growth factor (PDGF)- and
transforming growth factor (TGF)-β-like signals to promote HSC migration and activation. In addition, blocking endogenous
Gal-1 expression suppressed PDGF- and TGF-β1-induced signaling, migration, and gene expression in HSCs.
Methionine and
choline-deficient diet (MCD)-induced
collagen deposition and HSC activation were attenuated in Gal-1-null mice compared to wild-type mice. In summary, we concluded that glycosylation-dependent
Gal-1/NRP-1 interactions activate TGF-β and PDGF-like signaling to promote the migration and activation of HSCs. Therefore, targeting
Gal-1/NRP-1 interactions could be developed into
liver fibrosis therapy.